Last reviewed · How we verify

NCT03337061: MMI

A Trial of Mindfulness Meditation for Chronic Insomnia

Withdrawn NA Last updated 18 February 2020
What this trial tests

NA trial testing Mindfulness Meditation in Insomnia. Withdrawn.

Timeline
1 May 2018
Primary endpoint
1 August 2018
1 August 2018

Quick facts

Lead sponsorGuy's and St Thomas' NHS Foundation Trust
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Start date1 May 2018
Primary completion1 August 2018
Estimated completion1 August 2018

Drugs / interventions tested

Conditions studied

Sponsor

Guy's and St Thomas' NHS Foundation Trust

Who can join

18 and older, any sex, with Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of mediation therapies on measures of sleep and arousal for people with chronic insomnia and with this the viability of smartphone delivered meditation based approaches at a population level.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mindfulness Meditation

Trials testing the same drug.

Other recruiting trials for Insomnia

Currently open trials in the same condition.

Other Guy's and St Thomas' NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03337061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing